Portolan Capital Management, LLC Inotiv, Inc. Transaction History

Portolan Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$9.56 - $25.91 $3.74 Million - $10.1 Million	-390,988 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$18.52 - $40.41 $6.25 Million - $13.6 Million	-337,407 Reduced 46.32%	390,988 $10.2 Million
Q4 2021 Feb 14, 2022	SELL	$30.55 - $57.88 $533,830 - $1.01 Million	-17,474 Reduced 2.34%	728,395 $30.6 Million
Q3 2021 Nov 15, 2021	BUY	$23.69 - $49.93 $6.97 Million - $14.7 Million	294,068 Added 65.09%	745,869 $21.8 Million
Q2 2021 Aug 16, 2021	BUY	$18.9 - $31.42 $4.65 Million - $7.73 Million	245,987 Added 119.52%	451,801 $12.1 Million
Q1 2021 May 17, 2021	BUY	$11.55 - $20.3 $2.38 Million - $4.18 Million	205,814 New	205,814 $4.12 Million

3.67M

1.1K

21.3K

Ticker NOTV
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 25,594,500
Market Cap $104M
Description
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...

Get notified when there are updates to the investment portfolio of Portolan Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Portolan Capital Management, LLC with notifications on news.